Results 271 to 280 of about 18,960 (304)
Some of the next articles are maybe not open access.
[Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone].
Die Pharmazie, 2000The enantinomers of chlormezanone (1) may be achieved by enantioselective HPLC separation with a yield of 98% using a OD-Daicel column. Both enantiomers bind to human serum albumin (HSA) at pH 7.4 to a range of 11-12%. Binding to the globuline fractions is much less (2-4%, equilibrium dialysis, validation by ultrafiltration).
A, Seeling, H, Oelschläger, D, Rothley
openaire +1 more source
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Kimberly D Miller +2 more
exaly
Pharmacology of a new centrally acting muscle relaxant
Pharmacological Research Communications, 1988Pál Berzsenyi +3 more
openaire +1 more source
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Centrally Acting Skeletal Muscle Relaxants
2016Ruben Vardanyan, Victor Hruby
openaire +1 more source
CENTRALLY ACTING MUSCLE RELAXANTS AND SPINAL CORD ACTIVITY
Australian Journal of Experimental Biology and Medical Science, 1969DP Crankshaw, C Raper
openaire +1 more source